15-38253184-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_152594.3(SPRED1):c.-2A>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000696 in 1,579,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000074 ( 0 hom. )
Consequence
SPRED1
NM_152594.3 5_prime_UTR
NM_152594.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.67
Genes affected
SPRED1 (HGNC:20249): (sprouty related EVH1 domain containing 1) The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BS2
High AC in GnomAdExome4 at 106 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPRED1 | NM_152594.3 | c.-2A>T | 5_prime_UTR_variant | 1/7 | ENST00000299084.9 | NP_689807.1 | ||
SPRED1 | XM_005254202.4 | c.-2A>T | 5_prime_UTR_variant | 1/8 | XP_005254259.1 | |||
SPRED1 | XM_047432199.1 | c.-165A>T | 5_prime_UTR_variant | 1/9 | XP_047288155.1 | |||
SPRED1 | XM_047432200.1 | c.-129A>T | 5_prime_UTR_variant | 1/8 | XP_047288156.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPRED1 | ENST00000299084.9 | c.-2A>T | 5_prime_UTR_variant | 1/7 | 1 | NM_152594.3 | ENSP00000299084 | P1 | ||
SPRED1 | ENST00000561317.1 | c.-129A>T | 5_prime_UTR_variant | 1/6 | 4 | ENSP00000453680 | ||||
SPRED1 | ENST00000561205.1 | n.337A>T | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152124Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
152124
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000101 AC: 2AN: 198896Hom.: 0 AF XY: 0.0000188 AC XY: 2AN XY: 106180
GnomAD3 exomes
AF:
AC:
2
AN:
198896
Hom.:
AF XY:
AC XY:
2
AN XY:
106180
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000743 AC: 106AN: 1427514Hom.: 0 Cov.: 31 AF XY: 0.0000608 AC XY: 43AN XY: 706668
GnomAD4 exome
AF:
AC:
106
AN:
1427514
Hom.:
Cov.:
31
AF XY:
AC XY:
43
AN XY:
706668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152124Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74300
GnomAD4 genome
AF:
AC:
4
AN:
152124
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74300
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2021 | The c.-2A>T variant is located in the 5' untranslated region (5’ UTR) of the SPRED1 gene. This variant results from an A to T substitution 2 nucleotides upstream from the first translated codon. Based on nucleotide sequence alignment, this position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Noonan syndrome and Noonan-related syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Sep 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at